GameChangers: New GLP Data for Sleep Apnea and Weight Loss

GLP1 usage is on the rise. This week on GameChangers, we discuss the latest data on using GLP-1s for sleep apnea and weight loss.

The GameChanger: Several new studies suggest GLP-1 and GLP/GIP medications have positive clinical impact on sleep apnea and weight loss.

Upon successful completion of this course, learners should be able to:
1. Discuss the use of GLP-1 medications in the treatment of obstructive sleep apnea.
2. Discuss the relative weight loss in a recent study between a GLP-1 and GLP/GIP drugs.

Guests
Geoffrey C. Wall, PharmD, FCCP, BCPS, CG
Professor of Clinical Sciences
Drake University College of Pharmacy and Health Sciences

Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad

Dr. Wall is a member of the Janssen Speaker’s Bureau.
Dr. Galdo’s spouse is an employee of Eli Lilly.

All relevant financial relationships have been mitigated.

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Release Date: July 29, 2024
Planned Expiration Date: July 29, 2025

Universal Activity Number (UAN): 0107-0000-24-238-H01-P

Application-based CPE Activity

CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net.

¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.

Additional information

Duration	0h 30m
Topic Designator	Disease State/Drug Therapy
ACPE	Yes
ACPE Topic	01 Drug Therapy
Role	Pharmacist
Media-Type	Podcast
Release Date	7/29/24
CEUs	0.05
Rating	5
ACPE Number	0107-0000-24-238-H01-P